Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractPhosphatidylcholine profile-mediated group recognition in catfish    Next AbstractTaste and pheromone perception in mammals and flies »

PLoS One


Title:Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer
Author(s):Matsumura K; Opiekun M; Oka H; Vachani A; Albelda SM; Yamazaki K; Beauchamp GK;
Address:"Monell Chemical Senses Center, Philadelphia, Pennsylvania, United States of America"
Journal Title:PLoS One
Year:2010
Volume:20100127
Issue:1
Page Number:e8819 -
DOI: 10.1371/journal.pone.0008819
ISSN/ISBN:1932-6203 (Electronic) 1932-6203 (Linking)
Abstract:"A potential strategy for diagnosing lung cancer, the leading cause of cancer-related death, is to identify metabolic signatures (biomarkers) of the disease. Although data supports the hypothesis that volatile compounds can be detected in the breath of lung cancer patients by the sense of smell or through bioanalytical techniques, analysis of breath samples is cumbersome and technically challenging, thus limiting its applicability. The hypothesis explored here is that variations in small molecular weight volatile organic compounds ('odorants') in urine could be used as biomarkers for lung cancer. To demonstrate the presence and chemical structures of volatile biomarkers, we studied mouse olfactory-guided behavior and metabolomics of volatile constituents of urine. Sensor mice could be trained to discriminate between odors of mice with and without experimental tumors demonstrating that volatile odorants are sufficient to identify tumor-bearing mice. Consistent with this result, chemical analyses of urinary volatiles demonstrated that the amounts of several compounds were dramatically different between tumor and control mice. Using principal component analysis and supervised machine-learning, we accurately discriminated between tumor and control groups, a result that was cross validated with novel test groups. Although there were shared differences between experimental and control animals in the two tumor models, we also found chemical differences between these models, demonstrating tumor-based specificity. The success of these studies provides a novel proof-of-principle demonstration of lung tumor diagnosis through urinary volatile odorants. This work should provide an impetus for similar searches for volatile diagnostic biomarkers in the urine of human lung cancer patients"
Keywords:"Animals;Animals Behavior, Animal Biomarkers, Tumor/chemistry/*urine *Disease Models, Animal Lung Neoplasms/*urine Mice *Odorants Smell Volatilization;"
Notes:"MedlineMatsumura, Koichi Opiekun, Maryanne Oka, Hiroaki Vachani, Anil Albelda, Steven M Yamazaki, Kunio Beauchamp, Gary K eng Research Support, Non-U.S. Gov't 2010/01/30 PLoS One. 2010 Jan 27; 5(1):e8819. doi: 10.1371/journal.pone.0008819"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 22-11-2024